MRUS
Merus N.V. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +0.9% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.50M | +21.1% | $147.08M | 0.0% | ▲ Add | 3 | SEC ↗ ×8 |
| 2 | T. Rowe Price ✦ | 1.12M | -12.9% | $46.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Millennium Management ✦ | 883.57K | +87.0% | $37.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Marshall Wace ✦ | 862.09K | -23.2% | $36.25M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 5 | Two Sigma Investments ✦ | 507.74K | -14.4% | $21.35M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 359.05K | -45.9% | $15.10M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | Adage Capital Partners ✦ | 250.00K | +35.1% | $10.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (passive) | 221.52K | n/a | $9.31M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 52.64K | +1.0% | $2.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 23.84K | +75.9% | $1.00M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 8.10K | -96.3% | $340,731 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.